These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30528237)

  • 1. Discovery of a natural PI3Kδ inhibitor through virtual screening and biological assay study.
    Guo JF; Ning ZQ; Wu X; Qiao YJ; Wang X
    Biochem Biophys Res Commun; 2019 Jan; 508(3):709-714. PubMed ID: 30528237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a Natural Syk Inhibitor from Chinese Medicine through a Docking-Based Virtual Screening and Biological Assay Study.
    Wang X; Guo J; Ning Z; Wu X
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30487406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of New Phosphoinositide 3-kinase Delta (PI3Kδ) Inhibitors via Virtual Screening using Crystallography-derived Pharmacophore Modelling and QSAR Analysis.
    Al-Sha'er MA; Al-Aqtash RA; Taha MO
    Med Chem; 2019; 15(6):588-601. PubMed ID: 30799792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperidinyl-embeded chalcones possessing anti PI3Kδ inhibitory properties exhibit anti-atopic properties in preclinical models.
    Dumontet C; Beck G; Gardebien F; Haudecoeur R; Mathé D; Matera EL; Tourette A; Mattei E; Esmenjaud J; Boyère C; Nurisso A; Peuchmaur M; Pérès B; Bouchaud G; Magnan A; Monneret G; Boumendjel A
    Eur J Med Chem; 2018 Oct; 158():405-413. PubMed ID: 30237123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of virtual screening against phosphoinositide 3-kinase delta: Integration of common feature pharmacophore and multicomplex-based molecular docking.
    Zhu J; Meng H; Li X; Jia L; Xu L; Cai Y; Chen Y; Jin J; Yu L
    Comput Biol Chem; 2024 Apr; 109():108011. PubMed ID: 38198965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Novel PI3Kδ Selective Inhibitors by SVM-Based Multistage Virtual Screening and Molecular Dynamics Simulations.
    Liang JW; Wang S; Wang MY; Li SL; Li WQ; Meng FH
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient targeting of phosphoinositide 3-kinase acts as a roadblock in mast cells' route to allergy.
    Collmann E; Bohnacker T; Marone R; Dawson J; Rehberg M; Stringer R; Krombach F; Burkhart C; Hirsch E; Hollingworth GJ; Thomas M; Wymann MP
    J Allergy Clin Immunol; 2013 Oct; 132(4):959-68. PubMed ID: 23683463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of new dual spleen tyrosine kinase (Syk) and phosphoionositide-3-kinase δ (PI3Kδ) inhibitors using ligand and structure-based integrated ideal pharmacophore models.
    Kaur M; Silakari O
    SAR QSAR Environ Res; 2016 Jun; 27(6):469-99. PubMed ID: 27431536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Novel PI3Kδ Inhibitors Based on the p110δ Crystal Structure.
    Jia W; Luo S; Zhao W; Xu W; Zhong Y; Kong D
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of microRNA-223 promotes degranulation via the PI3K/Akt pathway by targeting IGF-1R in mast cells.
    Wang Q; Zhao DY; Xu H; Zhou H; Yang QY; Liu F; Zhou GP
    PLoS One; 2015; 10(4):e0123575. PubMed ID: 25875646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel quinazolinone derivatives as high potent and selective PI3Kδ and PI3Kδ/γ inhibitors.
    Ma CC; Zhang CM; Tang LQ; Liu ZP
    Eur J Med Chem; 2018 May; 151():9-17. PubMed ID: 29601991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic inhibits mast cell degranulation via suppression of early tyrosine phosphorylation events.
    Shim J; Kennedy RH; Weatherly LM; Hutchinson LM; Pelletier JH; Hashmi HN; Blais K; Velez A; Gosse JA
    J Appl Toxicol; 2016 Nov; 36(11):1446-59. PubMed ID: 27018130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting phosphoinositide 3-kinase δ for allergic asthma.
    Rowan WC; Smith JL; Affleck K; Amour A
    Biochem Soc Trans; 2012 Feb; 40(1):240-5. PubMed ID: 22260698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel inhaled Syk inhibitor blocks mast cell degranulation and early asthmatic response.
    Ramis I; Otal R; Carreño C; Domènech A; Eichhorn P; Orellana A; Maldonado M; De Alba J; Prats N; Fernández JC; Vidal B; Miralpeix M
    Pharmacol Res; 2015 Sep; 99():116-24. PubMed ID: 26051661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 7-(3-(piperazin-1-yl)phenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives as highly potent and selective PI3Kδ inhibitors.
    Qin LY; Ruan Z; Cherney RJ; Dhar TGM; Neels J; Weigelt CA; Sack JS; Srivastava AS; Cornelius LAM; Tino JA; Stefanski K; Gu X; Xie J; Susulic V; Yang X; Yarde-Chinn M; Skala S; Bosnius R; Goldstein C; Davies P; Ruepp S; Salter-Cid L; Bhide RS; Poss MA
    Bioorg Med Chem Lett; 2017 Feb; 27(4):855-861. PubMed ID: 28108251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of (S)-2-amino-N-(5-(6-chloro-5-(3-methylphenylsulfonamido)pyridin-3-yl)-4-methylthiazol-2-yl)-3-methylbutanamide (CHMFL-PI3KD-317) as a potent and selective phosphoinositide 3-kinase delta (PI3Kδ) inhibitor.
    Liang X; Li F; Chen C; Jiang Z; Wang A; Liu X; Ge J; Hu Z; Yu K; Wang W; Zou F; Liu Q; Wang B; Wang L; Zhang S; Wang Y; Liu Q; Liu J
    Eur J Med Chem; 2018 Aug; 156():831-846. PubMed ID: 30053721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockage by SP600125 of Fcepsilon receptor-induced degranulation and cytokine gene expression in mast cells is mediated through inhibition of phosphatidylinositol 3-kinase signalling pathway.
    Tanemura S; Momose H; Shimizu N; Kitagawa D; Seo J; Yamasaki T; Nakagawa K; Kajiho H; Penninger JM; Katada T; Nishina H
    J Biochem; 2009 Mar; 145(3):345-54. PubMed ID: 19106158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-221 promotes IgE-mediated activation of mast cells degranulation by PI3K/Akt/PLCγ/Ca(2+) pathway.
    Xu H; Gu LN; Yang QY; Zhao DY; Liu F
    J Bioenerg Biomembr; 2016 Jun; 48(3):293-9. PubMed ID: 27113449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-allergic potential of Typhonium blumei: Inhibition of degranulation via suppression of PI3K/PLCγ2 phosphorylation and calcium influx.
    Korinek M; Chen KM; Jiang YH; El-Shazly M; Stocker J; Chou CK; Hwang TL; Wu YC; Chen BH; Chang FR
    Phytomedicine; 2016 Dec; 23(14):1706-1715. PubMed ID: 27912872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.